Dianthus Therapeutics (DNTH) Current Leases (2022 - 2025)
Historic Current Leases for Dianthus Therapeutics (DNTH) over the last 4 years, with Q3 2025 value amounting to $217000.0.
- Dianthus Therapeutics' Current Leases fell 3022.51% to $217000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $217000.0, marking a year-over-year decrease of 3022.51%. This contributed to the annual value of $320000.0 for FY2024, which is 2326.14% down from last year.
- Latest data reveals that Dianthus Therapeutics reported Current Leases of $217000.0 as of Q3 2025, which was down 3022.51% from $211000.0 recorded in Q2 2025.
- In the past 5 years, Dianthus Therapeutics' Current Leases registered a high of $3.6 million during Q3 2022, and its lowest value of $211000.0 during Q2 2025.
- Its 4-year average for Current Leases is $1.0 million, with a median of $377000.0 in 2024.
- Over the last 5 years, Dianthus Therapeutics' Current Leases had its largest YoY gain of 1914.29% in 2023, and its largest YoY loss of 8859.43% in 2023.
- Over the past 4 years, Dianthus Therapeutics' Current Leases (Quarter) stood at $350000.0 in 2022, then increased by 19.14% to $417000.0 in 2023, then dropped by 23.26% to $320000.0 in 2024, then crashed by 32.19% to $217000.0 in 2025.
- Its Current Leases was $217000.0 in Q3 2025, compared to $211000.0 in Q2 2025 and $226000.0 in Q1 2025.